Table 1.
Clinical data for patients with PD, patients with ET, and controls.
PD group | ET group | Control group | p-value | |
---|---|---|---|---|
(n = 68) | (n = 25) | (n = 34) | ||
Gender (M/F) | 28/40 | 10/15 | 13/21 | 0.960 |
Age (years) | 64.54 ± 9.67 | 61.12 ± 11.16 | 63.53 ± 7.81 | 0.311 |
MMSE score | 27.75 ± 2.71 | 28.63 ± 1.86 | 28.80 ± 1.38 | 0.069 |
MoCA score | 24.98 ± 3.75 | 25.83 ± 3.28 | 26.33 ± 2.28 | 0.165 |
Disease duration (years) | 1.86 ± 1.68 | 8.60 ± 7.85 | < 0.001* | |
UPDRSIII tremor scores | 2.06 ± 1.74 | 3.67 ± 3.27 | 0.063 |
Significantly different; PD, Parkinson's Disease; ET, Essential Tremor; MMSE, Mini Mental State Examination; MoCA, Montreal Cognitive Assessment; UPDRS, United Parkinson's Disease Rating Scale.